Neurotransmitters at the Synapse: Types, Mechanisms, and Clinical Relevance
Neurotransmitters are endogenous chemicals that transmit signals across synapses. At chemical synapses (the vast majority), an action potential triggers Ca²⁺-dependent vesicular release into the synaptic cleft; binding to postsynaptic receptors generates excitatory or inhibitory postsynaptic potentials.
Major Neurotransmitter Systems
| Neurotransmitter | Primary Action | Key Pathways/Functions | Clinical Relevance |
|---|---|---|---|
| Glutamate | Excitatory (ionotropic: AMPA, NMDA, kainate; metabotropic) | Universal fast excitatory transmission; LTP/LTD, learning, memory | Excitotoxicity (stroke, ALS, TBI); NMDA antagonists (memantine, ketamine) |
| GABA | Inhibitory (GABAA ionotropic, GABAB metabotropic) | Universal fast inhibition; tone, oscillation, anxiety regulation | Benzodiazepines, barbiturates, gabapentinoids; epilepsy, anxiety, insomnia |
| Acetylcholine (ACh) | Excitatory (nicotinic) / modulatory (muscarinic) | NMJ, autonomic ganglia, basal forebrain (cognition), striatum, PNS | Myasthenia gravis (AChR Ab); Alzheimer's (cholinergic loss); anticholinergics |
| Dopamine (DA) | Modulatory (D1-like excitatory, D2-like inhibitory) | Mesolimbic (reward), nigrostriatal (motor), mesocortical (executive), tuberoinfundibular (prolactin) | Parkinson's (nigrostriatal loss); schizophrenia (mesolimbic hyper); addiction; antipsychotics |
| Serotonin (5-HT) | Modulatory (7 families, 14+ receptors) | Raphe nuclei → cortex, limbic, brainstem; mood, sleep, appetite, pain, GI motility | Depression/anxiety (SSRIs); migraine (triptans); 5-HT3 antiemetics; psychedelics (5-HT2A) |
| Norepinephrine (NE) | Modulatory (α/β adrenergic) | Locus coeruleus → widespread; arousal, attention, stress, autonomic | SNRIs, α2 agonists (clonidine), β-blockers; ADHD, depression, PTSD, hypertension |
Other Important Transmitters
- Glycine: Inhibitory in spinal cord/brainstem; startle disease (hyperekplexia).
- Endocannabinoids (2-AG, anandamide): Retrograde signaling; synaptic plasticity; CB1/CB2.
- Nitric Oxide (NO): Gaseous, retrograde; vasodilation, LTP.
- Neuropeptides (Substance P, NPY, Oxytocin, Orexin): Slow, modulatory, volume transmission.
Synaptic Integration
Postsynaptic neuron sums thousands of EPSPs/IPSPs spatially and temporally. Action potential fires at axon initial segment if threshold reached. Neuromodulators alter gain, plasticity, and network state.
Dysregulation & Disease
Imbalances underlie neurological/psychiatric disorders. Therapeutics target synthesis, release, reuptake, degradation, or receptors. Precision requires understanding circuit-level dynamics, not just single transmitters.
Brain & Nervous System - Related Articles
- Toddler Brain Tumor Symptoms: Signs, Causes & What to Do
- Understanding and Managing Hydrocephalus: Causes & Risks
- Meningiomas: Causes, Symptoms, and Types | [Your Brand/Website Name]
- Memory Loss After Mechanical Ventilation: Causes and Recovery
- Brachial Plexus Recovery: Gentle Activities for Toddlers
- Understanding and Caring for Individuals with Huntington's Disease
- 10 Modifiable Risk Factors That Harm Brain Health and Cognitive Function
